Most read article(s)

Open Access
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini, Ornella Rossetto, Roberto Eleopra and Cesare Montecucco
Jeffrey M. Witkin, ASSOCIATE EDITOR

Pharmacological Reviews April 2017, 69 (2) 200-235; DOI: https://doi.org/10.1124/pr.116.012658
You have access
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts and Daniel Hoyer
Eliot H. Ohlstein, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 310-520; DOI: https://doi.org/10.1124/pr.118.015552
Open Access
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai-Ming Yu, Young Hee Choi and Mei-Juan Tu
RHIAN M. TOUYZ, ASSOCIATE EDITOR

Pharmacological Reviews October 2020, 72 (4) 862-898; DOI: https://doi.org/10.1124/pr.120.019554
Open Access
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
R. L. Carhart-Harris and K. J. Friston
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews July 2019, 71 (3) 316-344; DOI: https://doi.org/10.1124/pr.118.017160
You have access
Psychedelics
David E. Nichols
Eric L. Barker, ASSOCIATE EDITOR

Pharmacological Reviews April 2016, 68 (2) 264-355; DOI: https://doi.org/10.1124/pr.115.011478
Open Access
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio and Gabriella Gobbi
Michael Nader, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 202-277; DOI: https://doi.org/10.1124/pharmrev.120.000056
Open Access
Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches
Torsten Schöneberg and Ines Liebscher
Paul Insel, ASSOCIATE EDITOR

Pharmacological Reviews January 2021, 73 (1) 89-119; DOI: https://doi.org/10.1124/pharmrev.120.000011
You have access
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Astrid Nehlig
Stephen P. H. Alexander, ASSOCIATE EDITOR

Pharmacological Reviews April 2018, 70 (2) 384-411; DOI: https://doi.org/10.1124/pr.117.014407
You have access
Druggable Transcriptional Networks in the Human Neurogenic Epigenome
Gerald A. Higgins, Aaron M. Williams, Alex S. Ade, Hasan B. Alam and Brian D. Athey
Lori L. Isom, ASSOCIATE EDITOR

Pharmacological Reviews October 2019, 71 (4) 520-538; DOI: https://doi.org/10.1124/pr.119.017681
Open Access
The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway
V. Kapil, R. S. Khambata, D. A. Jones, K. Rathod, C. Primus, G. Massimo, J. M. Fukuto and A. Ahluwalia
Christopher J. Garland, ASSOCIATE EDITOR

Pharmacological Reviews July 2020, 72 (3) 692-766; DOI: https://doi.org/10.1124/pr.120.019240

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals